Oct 28, 2014
By: Margaret A. Hamburg, M.D., Commissioner, FDA
By: Margaret A. Hamburg, M.D., Commissioner, FDA
The tragic Ebola epidemic is an extraordinary global public health crisis, and FDA is taking extraordinary steps to be proactive and flexible in our response – whether it’s providing advice on medical product development, authorizing the emergency use of new diagnostic tools, quickly enabling access to investigational therapies, or working on the front lines in West Africa.
Read More: FDA as Part of a Coordinated Global Response on Ebola
No hay comentarios:
Publicar un comentario